ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/13 | 3,415 | 3,590 | 3,370 | 3,565 | +150 | +4.4% | 391,100 |
2023/11/10 | 2,958 | 3,435 | 2,953 | 3,415 | +410 | +13.6% | 654,400 |
2023/11/09 | 2,950 | 3,010 | 2,906 | 3,005 | +50 | +1.7% | 128,500 |
2023/11/08 | 2,971 | 2,984 | 2,934 | 2,955 | -1 | ±0% | 133,000 |
2023/11/07 | 2,960 | 2,970 | 2,933 | 2,956 | -1 | ±0% | 84,600 |
2023/11/06 | 3,000 | 3,000 | 2,939 | 2,957 | +7 | +0.2% | 83,600 |
2023/11/02 | 2,989 | 2,995 | 2,950 | 2,950 | -30 | -1% | 75,700 |
2023/11/01 | 3,000 | 3,010 | 2,968 | 2,980 | -12 | -0.4% | 70,000 |
2023/10/31 | 2,940 | 2,996 | 2,915 | 2,992 | +52 | +1.8% | 88,400 |
2023/10/30 | 2,962 | 2,978 | 2,921 | 2,940 | -9 | -0.3% | 47,300 |
2023/10/27 | 2,910 | 2,949 | 2,900 | 2,949 | +64 | +2.2% | 54,200 |
2023/10/26 | 2,880 | 2,940 | 2,880 | 2,885 | +1 | ±0% | 51,300 |
2023/10/25 | 2,933 | 2,936 | 2,884 | 2,884 | -36 | -1.2% | 34,600 |
2023/10/24 | 2,887 | 2,924 | 2,826 | 2,920 | +67 | +2.3% | 84,200 |
2023/10/23 | 2,866 | 2,895 | 2,847 | 2,853 | -47 | -1.6% | 32,100 |
2023/10/20 | 2,868 | 2,915 | 2,842 | 2,900 | +10 | +0.3% | 35,300 |
2023/10/19 | 2,885 | 2,918 | 2,870 | 2,890 | -8 | -0.3% | 39,900 |
2023/10/18 | 2,874 | 2,917 | 2,867 | 2,898 | +24 | +0.8% | 30,300 |
2023/10/17 | 2,892 | 2,903 | 2,867 | 2,874 | +16 | +0.6% | 34,000 |
2023/10/16 | 2,880 | 2,900 | 2,850 | 2,858 | -42 | -1.4% | 60,000 |
2023/10/13 | 2,978 | 2,978 | 2,897 | 2,900 | -88 | -2.9% | 98,800 |
2023/10/12 | 2,969 | 2,988 | 2,955 | 2,988 | +27 | +0.9% | 54,000 |
2023/10/11 | 2,970 | 3,005 | 2,954 | 2,961 | -2 | -0.1% | 79,300 |
2023/10/10 | 2,963 | 2,979 | 2,943 | 2,963 | +10 | +0.3% | 83,800 |
2023/10/06 | 2,968 | 2,996 | 2,923 | 2,953 | +5 | +0.2% | 57,400 |
2023/10/05 | 2,877 | 2,948 | 2,851 | 2,948 | +131 | +4.7% | 61,300 |
2023/10/04 | 2,830 | 2,873 | 2,810 | 2,817 | -38 | -1.3% | 89,400 |
2023/10/03 | 2,959 | 2,970 | 2,836 | 2,855 | -105 | -3.5% | 143,600 |
2023/10/02 | 2,980 | 3,030 | 2,954 | 2,960 | +1 | ±0% | 106,900 |
2023/09/29 | 3,050 | 3,065 | 2,892 | 2,959 | -86 | -2.8% | 199,500 |
2023/09/28 | 3,015 | 3,065 | 3,000 | 3,045 | ±0 | ±0% | 70,600 |
2023/09/27 | 3,050 | 3,065 | 2,983 | 3,045 | -5 | -0.2% | 84,500 |
2023/09/26 | 3,010 | 3,065 | 2,981 | 3,050 | +35 | +1.2% | 88,800 |
2023/09/25 | 2,908 | 3,015 | 2,908 | 3,015 | +129 | +4.5% | 155,300 |
2023/09/22 | 2,840 | 2,912 | 2,826 | 2,886 | +17 | +0.6% | 87,600 |
2023/09/21 | 2,926 | 2,926 | 2,852 | 2,869 | -57 | -1.9% | 143,200 |
2023/09/20 | 2,897 | 2,934 | 2,886 | 2,926 | +28 | +1% | 62,600 |
2023/09/19 | 2,904 | 2,975 | 2,873 | 2,898 | +3 | +0.1% | 158,900 |
2023/09/15 | 2,888 | 2,899 | 2,846 | 2,895 | +20 | +0.7% | 115,100 |
2023/09/14 | 2,830 | 2,897 | 2,818 | 2,875 | +55 | +2% | 104,900 |
2023/09/13 | 2,825 | 2,839 | 2,789 | 2,820 | +6 | +0.2% | 103,400 |
2023/09/12 | 2,720 | 2,814 | 2,720 | 2,814 | +94 | +3.5% | 119,700 |
2023/09/11 | 2,741 | 2,748 | 2,696 | 2,720 | -21 | -0.8% | 112,000 |
2023/09/08 | 2,740 | 2,761 | 2,736 | 2,741 | +19 | +0.7% | 56,200 |
2023/09/07 | 2,726 | 2,777 | 2,712 | 2,722 | +6 | +0.2% | 105,200 |
2023/09/06 | 2,711 | 2,731 | 2,698 | 2,716 | +8 | +0.3% | 77,000 |
2023/09/05 | 2,710 | 2,724 | 2,702 | 2,708 | ±0 | ±0% | 61,200 |
2023/09/04 | 2,727 | 2,770 | 2,694 | 2,708 | -6 | -0.2% | 144,100 |
2023/09/01 | 2,714 | 2,722 | 2,690 | 2,714 | -11 | -0.4% | 117,700 |
2023/08/31 | 2,711 | 2,737 | 2,682 | 2,725 | -1 | ±0% | 111,300 |
351~
400
件表示中 / 2281件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 149,000円 | +1.2% | -13.9% | 5.70% | 8.79倍 | 1.63倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ダイト | 206,100円 | +4.5% | -33.7% | 3.40% | 20.76倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 28,000円 | +150.0% | - | 0.00% | - | 13.77倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
アンジェス | 7,000円 | +110.0% | - | 0.00% | - | 11.38倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
扶桑薬 | 231,500円 | +8.3% | +98.1% | 3.54% | 7.61倍 | 0.52倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム